| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |